Close Menu

Seventeen-year-old Shivani Sud, from North Carolina, won the Intel Science Talent Search and its $100,000 scholarship, according to an article in the Boston Globe. Using information publicly available (which included clinical samples), Sud identified genetic markers that predict recurrence of stage II colon cancer. With her model, she can also identify effective ways to treat those particular tumors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.